On the basis of this CD1a restricted pattern of expression and selective T-ALL target, a recent in vitro and in vivo study with anti-CD1a CAR-T cells showed promising anti-leukemia effects [15]. The gene discussed is CD1A; the disease is acute lymphoblastic leukemia.